Bionano Genomics, Inc.
BNGO
$1.14
-$0.03-2.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.44% | 71.58% | 63.58% | 63.10% | 51.82% |
| Total Depreciation and Amortization | -31.60% | -36.51% | -2.79% | -0.55% | 2.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.79% | -75.69% | -65.74% | -73.95% | -77.15% |
| Change in Net Operating Assets | -87.64% | 155.23% | 205.76% | 114.33% | 128.14% |
| Cash from Operations | 76.28% | 79.75% | 75.22% | 63.97% | 44.94% |
| Capital Expenditure | -- | 100.00% | 100.00% | 94.33% | 93.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -117.24% | -184.32% | -126.21% | -78.28% | 187.12% |
| Cash from Investing | -117.26% | -188.95% | -126.65% | -77.93% | 205.65% |
| Total Debt Issued | -- | -100.00% | -100.00% | -77.50% | -77.50% |
| Total Debt Repaid | 92.51% | 90.50% | 90.74% | 32.41% | -630.16% |
| Issuance of Common Stock | -30.01% | -26.41% | -35.86% | -27.04% | -23.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.94% | 87.81% | 79.10% | 29.14% | 32.68% |
| Cash from Financing | 275.66% | -48.29% | -61.25% | -75.66% | -112.02% |
| Foreign Exchange rate Adjustments | -57.14% | -148.89% | -218.18% | 233.33% | -110.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.29% | 76.22% | -377.80% | -207.54% | -168.25% |